Document Detail


9p21 deletion in the diagnosis of malignant mesothelioma, using fluorescence in situ hybridization analysis.
MedLine Citation:
PMID:  20518890     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Homozygous deletion of 9p21, the locus harboring the p16 gene, has been reported as one of the most common genetic alterations in malignant mesotheliomas (MMs). Previous studies showed that this alteration might be useful for differentiating benign from malignant mesothelial tumors in cytology and surgical specimens. Although the diagnostic utility of 9p21 homozygous deletion by fluorescence in situ hybridization (FISH) analysis has been reported only recently, it has not been well demonstrated. The purpose of this study is to evaluate the diagnostic utility of 9p21 homozygous deletion assessed by FISH in mesothelial neoplasm and hyperplasia of Japanese patients using paraffin-embedded tissue. Simultaneously, p16 protein immunoexpression was explored as a potential diagnostic aid. FISH analysis demonstrated 9p21 deletion in 35 of 40 cases with MM (88%) (P < 0.001). In contrast, no cases of adenomatoid tumor, benign mesothelial multicystic tumor, reactive mesothelial hyperplasia or pleuritis showed 9p21 deletion (P < 0.005). 9p21 homozygous deletion correlated well with p16 protein expression in the tumor cells. Our study suggests that 9p21 homozygous deletion assessed by FISH on paraffin-embedded tissue may be very useful for differentiating MM from reactive mesothelial proliferation.
Authors:
Maiko Takeda; Takahiko Kasai; Yasunori Enomoto; Masato Takano; Kouhei Morita; Eiji Kadota; Akitaka Nonomura
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Pathology international     Volume:  60     ISSN:  1440-1827     ISO Abbreviation:  Pathol. Int.     Publication Date:  2010 May 
Date Detail:
Created Date:  2010-06-03     Completed Date:  2010-09-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9431380     Medline TA:  Pathol Int     Country:  Australia    
Other Details:
Languages:  eng     Pagination:  395-9     Citation Subset:  IM    
Affiliation:
Department of Diagnostic Pathology, Nara Medical University School of Medicine, Nara, Japan. maikot@naramed-u.ac.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Chromosomes, Human, Pair 9*
DNA, Neoplasm / analysis
Epithelium / pathology
Female
Gene Deletion
Gene Dosage
Genes, p16*
Heart Neoplasms / diagnosis*,  genetics,  metabolism
Humans
In Situ Hybridization, Fluorescence / methods*
Mesothelioma / diagnosis*,  genetics,  metabolism
Pericardium / metabolism,  pathology
Peritoneal Neoplasms / diagnosis*,  genetics,  metabolism
Pleural Neoplasms / diagnosis*,  genetics,  metabolism
Tumor Markers, Biological / genetics,  metabolism
Chemical
Reg. No./Substance:
0/DNA, Neoplasm; 0/Tumor Markers, Biological

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Detection of telomerase activity in cultured cells and tumor tissue of lung carcinoma by modified te...
Next Document:  Steroid and Xenobiotic Receptor (SXR) as a possible prognostic marker in epithelial ovarian cancer.